Lon Cardon, Ph.D., FMedSci, an internationally recognized human geneticist, joined The Jackson Laboratory as president and chief executive officer in November 2021. From 2017 to 2021, he was chief scientific officer and chief scientific strategy officer at BioMarin Pharmaceutical Inc. Before joining BioMarin, Cardon held leadership roles at GlaxoSmithKline.Cardon spent the first half of his career in academic research. From 1998-2006 he was a faculty member at the University of Oxford, initially as head of bioinformatics and statistical genetics at the Wellcome Trust Center for Human Genetics, and later as a Wellcome Trust principal fellow and professor of bioinformatics. He was a professor of biostatistics at the University of Washington and co-chair of the Herbold Bioinformatics Program at the Fred Hutchinson Cancer Research Center (2006-2008).Cardon conducted his Ph.D. research at the Institute for Behavior Genetics at the University of Colorado Boulder and completed postdoctoral training in mathematics at Stanford University. His research groups have been involved in large international genetics initiatives that helped to create the present global genomics research infrastructure, including the first Genome-Wide Association Studies; the discovery of numerous genes responsible for rare diseases; and the development of new treatments for genetic disorders.